close_game
close_game

Dilip Kumar’s brother Aslam Khan dies, had tested positive for Covid-19

Hindustan Times | By, New Delhi
Aug 21, 2020 09:57 AM IST

Dilip Kumar’s younger brother Aslam Khan has died in Mumbai. He had tested positive for Covid-19 and was suffering from diabetes, hypertension and ischaemic heart disease.

Aslam Khan, the younger brother of veteran actor Dilip Kumar, died early on Friday morning. He had diabetes, hypertension and ischaemic heart disease. He had tested positive for Covid-19. The news of his death was confirmed by Lilavati Hospital in Mumbai.

Dilip Kumar’s brother Aslam Khan has died.
Dilip Kumar’s brother Aslam Khan has died.

Two of Dilip Kumar’s brothers, Aslam and Eshan Khan, were admitted to Lilavati Hospital last Saturday. After Aslam complained of breathlessness, he was rushed to the hospital, along with Eshan. Both of them tested positive for Covid-19 and were immediately admitted at the coronavirus ward of the hospital. Their oxygen saturation had dropped below 80%.

Dr Jalil Parker from the hospital had earlier told Hindustan Times, “They have been kept in ICU but we haven’t intubated them as yet. Considering their age and pre-condition health issues like diabetes and hypertension, we have to be extra careful while treating them.” Eshan is about 90 years of age while Aslam Khan was a few years younger.

Catch every big hit, every wicket with Crickit, a one stop destination for Live Scores, Match Stats, Infographics & much more. Explore now!.

Get more updates from Bollywood, Taylor Swift, Hollywood, Music and Web Series along with Latest Entertainment News at Hindustan Times.
Catch every big hit, every wicket with Crickit, a one stop destination for Live Scores, Match Stats, Infographics & much more. Explore now!.

Get more updates from Bollywood, Taylor Swift, Hollywood, Music and Web Series along with Latest Entertainment News at Hindustan Times.
SHARE THIS ARTICLE ON
SHARE
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Monday, May 19, 2025
Follow Us On